Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: An Integrated Narrative Review from Molecular Mechanisms to Nutritional and Bioactive Strategies
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the hepatic manifestation of systemic metabolic dysfunction and serves as an independent risk factor for cardiovascular disease (CVD), the primary cause of mortality in affected individuals. Rather than separate entities,...